Bayer using AI to improve disease diagnosis, drug design
Drugmakers have embraced artificial intelligence - using computers to analyze reams of data and then make predictions or recommendations. Germany's Bayer has been testing how the t…
Drugmakers have embraced artificial intelligence - using computers to analyze reams of data and then make predictions or recommendations. Germany's Bayer has been testing how the t…